胃内滞留型ドラッグデリバリーシステムのアウトソーシングの世界市場レポート 2025年

胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.9％で20億3,000万米ドルに成長します。予測期間の成長は、外来センター数の増加、患者のコンプライアンスと利便性の重視、慢性疾患の罹患率の上昇、個別化医療の増加、高齢化人口の増加などに起因すると考えられます。予測期間における主な動向としては、ポリマー科学の進歩、製剤技術、生体接着システム、新規ポリマー、薬剤放出調整剤、胃内滞留性剤形の開発、デジタルヘルス技術の統合、スマート胃内滞留性システム、標的ドラッグデリバリーなどが挙げられます。

胃腸障害の有病率の増加は、胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場の拡大を促進すると予想されます。胃腸障害には、胃、肝臓、胆嚢、腸、膵臓などの消化器系に影響を及ぼす幅広い疾患が含まれます。これらの疾患の増加は、人口の高齢化、抗生物質の使用、感染症、食生活の変化、ストレス、ライフスタイル要因、肥満などの要因に起因しています。消化管伸展性ドラッグデリバリーシステムをアウトソーシングすることで、製薬会社は増加する消化管疾患の負担に対処するために必要な専門知識とリソースを利用することができ、最終的に患者の転帰と生活の質を改善することができます。例えば、米国を拠点とする健康団体である米国がん協会（ACS）は2023年1月、消化器がんが3.18%増加し、米国における2021年の338,090例から348,840例に増加すると報告しています。したがって、消化器疾患の有病率の上昇が胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場の成長を促進しています。

胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場の主なプレーヤーは、ドラッグデリバリーの効率を改善し、患者の利便性を高めるために、RTF（Ready-to-Fill）結腸機能性カプセルなどの革新的なソリューションの開発に注力しています。RTF（Ready-to-Fill）大腸機能性カプセルは、あらかじめ製造された空のカプセルで、大腸への標的送達を目的とした特定の製剤や有効成分を充填するように設計されています。例えば、2024年9月、ドイツを拠点とする先進ドラッグデリバリーのリーダーであるエボニックは、回腸・結腸領域に経口薬を直接送達するように設計されたEUDRACAP結腸機能性カプセルを発表しました。このカプセルは、生きた生物治療製品（LBP）のような敏感な有効成分を運ぶことを特別に意図した、市場初のレディ・トゥ・フィル・オプションです。現在、テクニカルグレードで提供されているが、GMPグレードのバージョンも開発中です。EUDRACAP colonは、製剤化を容易にし、市場投入までの時間を短縮することで、経口薬の開発プロセスを簡素化し、胃内滞留性ドラッグデリバリーシステムにおける重要な前進を示すものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場：成長率分析
• 世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場の実績：規模と成長, 2019-2024
• 世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場の予測：規模と成長, 2024-2029, 2034F
• 世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• フローティングシステム
• 生体接着システム
• その他のタイプ
• 世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場剤形別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タブレット
• 液体
• マイクロスフェア
• カプセル
• その他の剤形
• 世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 胃食道逆流症（GERD）
• 神経疾患
• その他の用途
• 世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬会社
• 契約調査機関（CRO）
• その他のエンドユーザー
• 世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場浮体式システムのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単一ユニットシステム
• 複数の単位系
• 世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場、生体接着システムのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハイドロゲル
• 粘膜付着性ポリマー
• 世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 磁気アシストシステム
• 高密度システム
• 浸透圧システム

第7章 地域別・国別分析

• 世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場：競合情勢
• 胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AstraZeneca plc
• Novartis AG
• GlaxoSmithKline plc
• Evonik Industries AG
• Alcon Inc.
• SGS SA
• Lonza Group AG
• FMC Corporation
• Sun Pharmaceutical Industries Ltd.
• Catalent Inc.
• AptarGroup Inc.
• Cadila Pharmaceuticals
• Ashland Global Holdings Inc
• Lupin Limited
• Torrent Pharmaceuticals Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場2029：新たな機会を提供する国
• 胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場2029：新たな機会を提供するセグメント
• 胃内滞留型ドラッグデリバリーシステムのアウトソーシング市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Gastroretentive drug delivery systems outsourcing involves pharmaceutical firms engaging external service providers or contract research organizations (CROs) to create and produce drug delivery systems intended to extend the duration of medication within the gastrointestinal (GI) tract. These systems are crafted to boost drug absorption, enhance therapeutic effectiveness, and optimize patient results.

The primary categories of gastroretentive drug delivery systems outsourcing include floating systems, bioadhesive systems, and other variants. A floating drug delivery system (FDDS) is tailored to extend the retention period of medications in the stomach and upper gastrointestinal tract. These systems come in various dosage forms such as tablets, liquids, microspheres, capsules, and others, serving diverse applications such as gastroesophageal reflux disease (GERD), neurological disorders, and more. They are utilized by a range of end-users, including pharmaceutical companies, contract research organizations (CROs), and others.

The gastroretentive drug delivery systems outsourcing market research report is one of a series of new reports from The Business Research Company that provides gastroretentive drug delivery systems outsourcing market statistics, including gastroretentive drug delivery systems outsourcing industry global market size, regional shares, competitors with a gastroretentive drug delivery systems outsourcing market share, detailed gastroretentive drug delivery systems outsourcing market segments, market trends, and opportunities, and any further data you may need to thrive in the gastroretentive drug delivery systems outsourcing industry. This gastroretentive drug delivery systems outsourcing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gastroretentive drug delivery systems outsourcing market size has grown strongly in recent years. It will grow from $1.39 billion in 2024 to $1.5 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to the rising incidence of stomach and small intestine disorders, rising drug delivery systems, rising prevalence of gastric cancer, rise in government initiatives, and increase in the number of hospitals.

The gastroretentive drug delivery systems outsourcing market size is expected to see strong growth in the next few years. It will grow to $2.03 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increase in the number of ambulatory centers, the focus on patient compliance and convenience, the rising incidence of chronic diseases, increasing personalized medicine, and the growing aging population. Major trends in the forecast period include advancements in polymer science, formulation technologies, bioadhesive systems, novel polymers, drug release modifiers, the development of gastroretentive dosage forms, the integration of digital health technologies, smart gastroretentive systems, and targeted drug delivery.

The growing prevalence of gastrointestinal disorders is expected to drive the expansion of the gastroretentive drug delivery systems outsourcing market. Gastrointestinal disorders encompass a wide range of diseases affecting the digestive system, including the stomach, liver, gallbladder, intestines, and pancreas. The rise in these disorders is attributed to factors such as aging populations, antibiotic use, infectious agents, dietary changes, stress, lifestyle factors, and obesity. Outsourcing gastroretentive drug delivery systems enables pharmaceutical companies to access the expertise and resources needed to address the increasing burden of gastrointestinal conditions, ultimately improving patient outcomes and quality of life. For instance, in January 2023, the American Cancer Society (ACS), a US-based health organization, reported a 3.18% increase in gastrointestinal cancers, rising to 348,840 cases from 338,090 in 2021 in the United States. Therefore, the rising prevalence of gastrointestinal disorders is driving the growth of the gastroretentive drug delivery systems outsourcing market.

Key players in the gastroretentive drug delivery systems outsourcing market are concentrating on developing innovative solutions, such as ready-to-fill (RTF) colon functional capsules, to improve drug delivery efficiency and enhance patient convenience. Ready-to-fill (RTF) colon functional capsules are pre-manufactured, empty capsules designed to be filled with specific formulations or active ingredients intended for targeted delivery to the colon. For example, in September 2024, Evonik, a Germany-based leader in advanced drug delivery, introduced its EUDRACAP colon functional capsules, designed to deliver oral medications directly to the ileo-colonic region. These capsules represent the first ready-to-fill option in the market, specifically intended to carry sensitive active ingredients like live biotherapeutic products (LBPs). Currently available in technical grade, a GMP-grade version is under development. EUDRACAP colon simplifies the oral drug development process by easing formulation and speeding up time to market, marking a significant step forward in gastroretentive drug delivery systems.

In August 2022, Catalent Inc., a pharmaceutical company headquartered in the United States, completed the acquisition of Metrics Contract Services (Metrics) for an estimated $475 million. Through this strategic move, Catalent intends to fortify its integrated capabilities in oral solid formulation development, manufacturing, and packaging, thereby augmenting its capacity to handle potent compounds and improving its capacity to satisfy customer demands and patient requirements. Metrics Contract Services, based in the United States, is a contract development and manufacturing organization (CDMO) that specializes in providing services for pharmaceutical product development, manufacturing, and analytical testing.

Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Evonik Industries AG, Alcon Inc., SGS SA, Lonza Group AG, FMC Corporation, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc, Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Ranbaxy Laboratories Limited, Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Assertio Therapeutics Inc., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.

North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gastroretentive drug delivery systems outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The gastroretentive drug delivery systems outsourcing market consists of revenues earned by entities by providing services such as analytical and testing services, formulation development, quality assurance and control, and clinical trial services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastroretentive drug delivery systems outsourcing market also includes sales of bioadhesive systems, swelling systems, and high-density systems, and floating systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastroretentive Drug Delivery Systems Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastroretentive drug delivery systems outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastroretentive drug delivery systems outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastroretentive drug delivery systems outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Floating Systems; Bioadhesive Systems; Other Types
• 2) By Dosage Form: Tablets; Liquid; Microspheres; Capsule; Other Dosage Forms
• 3) By Application: Gastroesophageal Reflux Disease (GERD); Neurological Disorders; Other Applications
• 4) By End User: Pharmaceutical Companies; Contract Research Organizations (CROs); Other End Users
• Subsegments:
• 1) Floating Systems: Single Unit Systems; Multiple Unit Systems
• 2) Bioadhesive Systems: Hydrogels; Mucoadhesive Polymers
• 3) Other Types: Magnetically Assisted Systems; High-Density Systems; Osmotic Systems
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gastroretentive Drug Delivery Systems Outsourcing Market Characteristics

3. Gastroretentive Drug Delivery Systems Outsourcing Market Trends And Strategies

4. Gastroretentive Drug Delivery Systems Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Gastroretentive Drug Delivery Systems Outsourcing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gastroretentive Drug Delivery Systems Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gastroretentive Drug Delivery Systems Outsourcing Market Growth Rate Analysis
• 5.4. Global Gastroretentive Drug Delivery Systems Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gastroretentive Drug Delivery Systems Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gastroretentive Drug Delivery Systems Outsourcing Total Addressable Market (TAM)

6. Gastroretentive Drug Delivery Systems Outsourcing Market Segmentation

• 6.1. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Floating Systems
• Bioadhesive Systems
• Other Types
• 6.2. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Liquid
• Microspheres
• Capsule
• Other Dosage Forms
• 6.3. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gastroesophageal Reflux Disease (GERD)
• Neurological Disorders
• Other Applications
• 6.4. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Contract Research Organizations (CROs)
• Other End Users
• 6.5. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Sub-Segmentation Of Floating Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Unit Systems
• Multiple Unit Systems
• 6.6. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Sub-Segmentation Of Bioadhesive Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hydrogels
• Mucoadhesive Polymers
• 6.7. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Magnetically Assisted Systems
• High-Density Systems
• Osmotic Systems

7. Gastroretentive Drug Delivery Systems Outsourcing Market Regional And Country Analysis

• 7.1. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gastroretentive Drug Delivery Systems Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market

• 8.1. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gastroretentive Drug Delivery Systems Outsourcing Market

• 9.1. China Gastroretentive Drug Delivery Systems Outsourcing Market Overview
• 9.2. China Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gastroretentive Drug Delivery Systems Outsourcing Market

• 10.1. India Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gastroretentive Drug Delivery Systems Outsourcing Market

• 11.1. Japan Gastroretentive Drug Delivery Systems Outsourcing Market Overview
• 11.2. Japan Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gastroretentive Drug Delivery Systems Outsourcing Market

• 12.1. Australia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gastroretentive Drug Delivery Systems Outsourcing Market

• 13.1. Indonesia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market

• 14.1. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market Overview
• 14.2. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gastroretentive Drug Delivery Systems Outsourcing Market

• 15.1. Western Europe Gastroretentive Drug Delivery Systems Outsourcing Market Overview
• 15.2. Western Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gastroretentive Drug Delivery Systems Outsourcing Market

• 16.1. UK Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gastroretentive Drug Delivery Systems Outsourcing Market

• 17.1. Germany Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gastroretentive Drug Delivery Systems Outsourcing Market

• 18.1. France Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gastroretentive Drug Delivery Systems Outsourcing Market

• 19.1. Italy Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gastroretentive Drug Delivery Systems Outsourcing Market

• 20.1. Spain Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gastroretentive Drug Delivery Systems Outsourcing Market

• 21.1. Eastern Europe Gastroretentive Drug Delivery Systems Outsourcing Market Overview
• 21.2. Eastern Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gastroretentive Drug Delivery Systems Outsourcing Market

• 22.1. Russia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gastroretentive Drug Delivery Systems Outsourcing Market

• 23.1. North America Gastroretentive Drug Delivery Systems Outsourcing Market Overview
• 23.2. North America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gastroretentive Drug Delivery Systems Outsourcing Market

• 24.1. USA Gastroretentive Drug Delivery Systems Outsourcing Market Overview
• 24.2. USA Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gastroretentive Drug Delivery Systems Outsourcing Market

• 25.1. Canada Gastroretentive Drug Delivery Systems Outsourcing Market Overview
• 25.2. Canada Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gastroretentive Drug Delivery Systems Outsourcing Market

• 26.1. South America Gastroretentive Drug Delivery Systems Outsourcing Market Overview
• 26.2. South America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market

• 27.1. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market

• 28.1. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market Overview
• 28.2. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gastroretentive Drug Delivery Systems Outsourcing Market

• 29.1. Africa Gastroretentive Drug Delivery Systems Outsourcing Market Overview
• 29.2. Africa Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gastroretentive Drug Delivery Systems Outsourcing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gastroretentive Drug Delivery Systems Outsourcing Market Competitive Landscape And Company Profiles

• 30.1. Gastroretentive Drug Delivery Systems Outsourcing Market Competitive Landscape
• 30.2. Gastroretentive Drug Delivery Systems Outsourcing Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Gastroretentive Drug Delivery Systems Outsourcing Market Other Major And Innovative Companies

• 31.1. AstraZeneca plc
• 31.2. Novartis AG
• 31.3. GlaxoSmithKline plc
• 31.4. Evonik Industries AG
• 31.5. Alcon Inc.
• 31.6. SGS SA
• 31.7. Lonza Group AG
• 31.8. FMC Corporation
• 31.9. Sun Pharmaceutical Industries Ltd.
• 31.10. Catalent Inc.
• 31.11. AptarGroup Inc.
• 31.12. Cadila Pharmaceuticals
• 31.13. Ashland Global Holdings Inc
• 31.14. Lupin Limited
• 31.15. Torrent Pharmaceuticals Ltd.

32. Global Gastroretentive Drug Delivery Systems Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastroretentive Drug Delivery Systems Outsourcing Market

34. Recent Developments In The Gastroretentive Drug Delivery Systems Outsourcing Market

35. Gastroretentive Drug Delivery Systems Outsourcing Market High Potential Countries, Segments and Strategies

• 35.1 Gastroretentive Drug Delivery Systems Outsourcing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gastroretentive Drug Delivery Systems Outsourcing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gastroretentive Drug Delivery Systems Outsourcing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer